Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenvatinib, Sintilimab, and FOLFOX for Metastatic ICC
NCT04769908Phase 2Unknown
- Sponsor
- Sun Yat-sen University
- Start
- Feb 2021
- Primary completion
- Dec 2021
- Modality
- Small Molecules, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of lenvatinib, sintilimab in intrahepatic cholangiocarcinoma (ICC), sponsored by Sun Yat-sen University. Status: unknown.
02
Drugs
lenvatinibsintilimab
03
Conditions
intrahepatic cholangiocarcinoma (ICC)
Beyond the preview
Go deeper on NCT04769908.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04769908.